Target intelligence / Profile preview

F-box only protein 28 (FBXO28)

Target
FBXO28
Molecular classification
F-box protein, Ubiquitin ligase complex component (SCF complex), Other
01

Overview

F-box only protein 28 (FBXO28) is a member of the F-box protein family characterized by a conserved F-box motif of about 40 amino acids, enabling assembly into the SCF (SKP1–CUL1–F-box protein) E3 ubiquitin ligase complex[1][3][6]. As part of this complex, FBXO28 serves as a substrate-recognition component, interacting with SKP1 and cullin proteins to mediate ubiquitination and subsequent degradation of target proteins, often recognizing phosphorylated substrates[1][3]. FBXO28 has functional roles in regulating protein stability, mitotic progression, cell cycle transitions, and DNA decatenation through regulation of topoisomerase IIα activity[5][8]. Loss-of-function mutations or deletions in FBXO28 are implicated in developmental and epileptic encephalopathy 100, intellectual disability, seizures, and brain abnormalities, particularly as a driver gene in chromosome 1q41q42 microdeletion syndrome[3][4]. FBXO28 is essential for normal neurodevelopment but, as of now, there are no specific drugs known to target this protein directly, nor defined pharmacological mechanisms of action[3][4][7].

Other names
FBXO28F-box protein 28CENP-30Fbx28KIAA0483FLJ10766centromere protein 30DEE100
02

Biological functions

UbiquitinationProtein degradationCell cycle regulationMitotic progressionRegulation of DNA decatenation
03

Disease associations

Developmental and epileptic encephalopathyNeurodevelopmental disordersIntellectual disabilityBrain abnormalitiesMicrodeletion syndromes (chromosome 1q41q42)Other
04

Safety considerations

Potential involvement in essential neurodevelopmental processes may pose safety concerns if targeted systemically
05

Biomarkers

Deletions or pathogenic variants in FBXO28 for neurodevelopmental and epileptic encephalopathy 100

Beyond the preview

Go deeper on F-box only protein 28 (FBXO28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on F-box only protein 28 (FBXO28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call